-1.00.01.02.03.0CASSLRTDSYEQYF-1.00.01.02.03.04.05.0CASSLRTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
0 71 CASSLRTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [62, 63, 64, 65, 66, 68, 69, 70, 71, 74, 76, 139, 140, 141, 142, 143, 170, 179, 180, 228, 229, 231, 232, 233, 252, 253, 254, 255, 265, 266, 267, 274, 275, 301, 303, 304, 306, 307, 308, 310, 385, 388, 389, 390, 391, 392, 397, 399, 426, 427] 50 11 True CASSLRTDSYEQYF (23.9%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (23.9%) 178 (25.4%), 7736 (19.4%), 7301 (13.4%), 1886 (11.9%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLKTDSYEQYF-1.00.01.02.03.04.05.0CASSLKTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
1 230 CASSLKTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [62, 63, 64, 65, 66, 68, 69, 70, 71, 74, 76, 139, 140, 141, 142, 143, 170, 179, 180, 224, 227, 228, 229, 231, 232, 233, 252, 254, 255, 265, 266, 267, 274, 275, 301, 303, 304, 307, 308, 310, 385, 388, 389, 391, 392, 397, 399, 427] 48 11 True CASSLRTDSYEQYF (25.4%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (25.4%) 178 (27.0%), 7736 (17.5%), 1886 (12.7%), 7301 (11.1%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSFRTDSYEQYF-1.00.01.02.03.04.05.0CASSFRTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
2 63 CASSFRTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [53, 58, 60, 62, 63, 70, 74, 76, 139, 141, 142, 143, 169, 170, 229, 233, 252, 255, 264, 267, 274, 275, 298, 299, 300, 301, 303, 307, 308, 310, 345, 385, 388, 391, 397, 399, 427] 37 11 True CASSLRTDSYEQYF (32.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (32.0%) 178 (28.0%), 7736 (18.0%), 7301 (18.0%), 1886 (10.0%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSYRTDSYEQYF-1.00.01.02.03.04.05.0CASSYRTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
3 77 CASSYRTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [53, 58, 60, 62, 63, 70, 74, 76, 139, 141, 142, 143, 169, 170, 229, 233, 252, 255, 267, 274, 275, 299, 300, 301, 303, 307, 308, 310, 345, 385, 386, 388, 391, 397, 399, 427] 36 11 True CASSLRTDSYEQYF (32.7%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (32.7%) 178 (28.6%), 7736 (20.4%), 7301 (16.3%), 1886 (10.2%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSRRTDSYEQYF-1.00.01.02.03.04.05.0CASSRRTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
4 75 CASSRRTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [62, 63, 70, 72, 74, 76, 139, 141, 142, 143, 170, 182, 229, 233, 234, 252, 255, 267, 274, 275, 301, 303, 307, 308, 310, 311, 385, 388, 391, 397, 399, 427] 32 11 True CASSLRTDSYEQYF (35.6%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (35.6%) 178 (26.7%), 7736 (20.0%), 7301 (15.6%), 1886 (11.1%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLRSDSYEQYF-1.00.01.02.03.04.05.0CASSLRSDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
5 141 CASSLRSDSYEQYF TRBV28*01 TRBJ2-7*01 18 [60, 65, 68, 70, 140, 141, 169, 180, 227, 229, 231, 232, 233, 252, 253, 255, 267, 275, 299, 306, 307, 387, 388, 389, 390, 391, 392, 426, 427] 29 11 True CASSLRTDSYEQYF (39.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (39.0%) 7736 (24.4%), 178 (17.1%), 5649 (12.2%), 1886 (12.2%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLKSDSYEQYF-1.00.01.02.03.04.05.0CASSLKSDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
6 66 CASSLKSDSYEQYF TRBV28*01 TRBJ2-7*01 18 [60, 65, 70, 140, 141, 169, 227, 228, 229, 231, 233, 252, 253, 255, 265, 275, 299, 304, 306, 307, 387, 388, 389, 390, 391, 426, 427] 27 10 True CASSLRTDSYEQYF (41.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (41.0%) 7736 (23.1%), 178 (15.4%), 7301 (12.8%), 5649 (12.8%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.04.0CASSLRTNSYEQYF-1.00.01.02.03.04.05.0CASSLRTNSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
7 181 CASSLRTNSYEQYF TRBV28*01 TRBJ2-7*01 18 [68, 70, 140, 141, 180, 227, 229, 230, 231, 232, 233, 252, 253, 255, 265, 267, 275, 304, 306, 307, 388, 389, 390, 391, 392, 426, 427] 27 10 True CASSLRTDSYEQYF (41.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (41.0%) 7736 (23.1%), 5649 (15.4%), 1886 (12.8%), 178 (12.8%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.04.0CASSLRSNSYEQYF-1.00.01.02.03.04.05.0CASSLRSNSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
8 254 CASSLRSNSYEQYF TRBV28*01 TRBJ2-7*01 18 [65, 67, 70, 140, 141, 180, 227, 230, 231, 233, 253, 255, 264, 265, 275, 304, 305, 306, 307, 389, 390, 391, 392, 393, 426, 427] 26 10 True CASSLRTDSYEQYF (42.1%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (42.1%) 7736 (23.7%), 178 (15.8%), 7301 (13.2%), 1886 (13.2%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLRTDNYEQYF-1.00.01.02.03.04.05.0CASSLRTDNYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
9 233 CASSLRTDNYEQYF TRBV28*01 TRBJ2-7*01 18 [66, 68, 69, 70, 140, 141, 179, 180, 228, 229, 231, 232, 233, 234, 252, 254, 255, 267, 275, 307, 388, 389, 391, 392, 427] 25 10 True CASSLRTDSYEQYF (45.7%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (45.7%) 7736 (20.0%), 178 (20.0%), 5649 (17.1%), 1886 (14.3%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.04.0CASSLKTNSYEQYF0.01.02.03.04.05.0CASSLKTNSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
10 266 CASSLKTNSYEQYF TRBV28*01 TRBJ2-7*01 18 [65, 70, 141, 180, 227, 228, 229, 230, 233, 252, 253, 255, 265, 275, 304, 306, 307, 388, 390, 391, 392, 426, 427] 23 10 True CASSLRTDSYEQYF (48.5%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (48.5%) 7736 (24.2%), 5649 (15.2%), 178 (15.2%), 7301 (12.1%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSFRSDSYEQYF0.01.02.03.04.05.0CASSFRSDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
11 61 CASSFRSDSYEQYF TRBV28*01 TRBJ2-7*01 18 [53, 60, 61, 62, 65, 76, 140, 169, 170, 231, 250, 264, 274, 298, 299, 301, 345, 385, 389, 399] 20 10 True CASSFRTDSYEQYF (28.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSFRTDSYEQYF (28.0%) 178 (32.0%), 7736 (16.0%), 7301 (12.0%), 1886 (12.0%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLSTDSYEQYF0.01.02.03.04.05.0CASSLSTDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
12 72 CASSLSTDSYEQYF TRBV28*01 TRBJ2-7*01 18 [64, 70, 71, 141, 183, 229, 233, 252, 255, 266, 267, 275, 307, 311, 388, 391, 393, 427] 18 10 True CASSLRTDSYEQYF (61.5%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (61.5%) 7736 (23.1%), 178 (23.1%), 7301 (7.7%), 6913 (7.7%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.04.0CASSLKSNSYEQYF0.01.02.03.04.05.0CASSLKSNSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
13 228 CASSLKSNSYEQYF TRBV28*01 TRBJ2-7*01 18 [65, 67, 140, 180, 227, 229, 230, 231, 252, 253, 264, 265, 304, 305, 306, 388, 389, 390, 392, 393, 426] 21 9 True CASSLRSNSYEQYF (24.0%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRSNSYEQYF (24.0%) 7736 (24.0%), 7301 (16.0%), 5649 (16.0%), 1886 (12.0%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSLKTDQYEQYF0.01.02.03.04.05.0CASSLKTDQYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
14 67 CASSLKTDQYEQYF TRBV28*01 TRBJ2-7*01 18 [66, 68, 69, 70, 141, 179, 228, 229, 232, 233, 252, 254, 255, 275, 300, 307, 388, 391, 427] 19 9 True CASSLRTDSYEQYF (59.3%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSLRTDSYEQYF (59.3%) 178 (25.9%), 7736 (18.5%), 5649 (14.8%), 6499 (11.1%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.0CASSFKSDSYEQYF0.01.02.03.04.05.0CASSFKSDSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
15 170 CASSFKSDSYEQYF TRBV28*01 TRBJ2-7*01 18 [58, 60, 62, 65, 76, 140, 169, 170, 231, 250, 264, 274, 298, 299, 301, 385, 389] 17 9 True CASSFRTDSYEQYF (31.8%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSFRTDSYEQYF (31.8%) 178 (31.8%), 7736 (13.6%), 7301 (13.6%), 1886 (13.6%) COVID-19-Convalescent (100.0%)




-1.00.01.02.03.04.0CASSFRSNSYEQYF0.01.02.03.04.05.0CASSFRSNSYEQYF

clone_id cdr3_b_aa v_b_gene j_b_gene radius neighbors K_neighbors nsubject qpublic cdr3_b_aa.summary v_b_gene.summary j_b_gene.summary cdr3_b_aa.summary subject.summary cohort.summary
16 265 CASSFRSNSYEQYF TRBV28*01 TRBJ2-7*01 18 [60, 61, 62, 169, 227, 253, 264, 274, 297, 298, 299, 301, 302, 306, 385, 390, 426] 17 9 True CASSFRTDSYEQYF (31.8%) TRBV28*01 (100.0%) TRBJ2-7*01 (100.0%) CASSFRTDSYEQYF (31.8%) 7301 (31.8%), 178 (22.7%), 7736 (18.2%), 1005703 (4.5%) COVID-19-Convalescent (100.0%)